Product Images Gabapentin

This is a clinical trial report showing the mean pain score with a 4-week dose titration period followed by a 4-week fixed dose period with placebo and Gabapentin, 3600 mg/day. The baseline information is also included in the report.*

The text provides a table with four different treatments (placebo, Gabapentin 1800 mg/day, Gabapentin 2400 mg/day, and a fixed dose period) for pain management. The table shows data for mean pain scores at baseline and during the treatment period. There is not enough information to determine the condition being treated or the efficacy of the treatments.*

The text contains statistical data related to the proportion of patients in controlled PHN studies, specifically the percentage of responders (patients with a 50% reduction in pain score) at endpoint, for different treatments such as GBP 3600, PBO, GEBP 1800, GBP 2400. The figure shows different percentages ranging from 100% to 10%. Therefore, this text provides an overview of statistical data obtained in controlled PHN studies for different treatments.*

This text appears to be a label for a medication called "Neurontin 300mg". It comes in capsule form, is packaged by Bryant Ranck Prepack, and has an expiration date of MM/YY. The drug is produced by Alkem Laboratories Limited and has an NDC number. The label includes storage instructions to keep the drug at room temperature and a warning to keep it out of reach of children. The last line may be a UPC or barcode number.*